Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery - Trial NCT06320041
Access comprehensive clinical trial information for NCT06320041 through Pure Global AI's free database. This Phase 4 trial is sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine and is currently Not yet recruiting. The study focuses on Postoperative Pain. Target enrollment is 162 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Timeline & Enrollment
Phase 4
Apr 01, 2024
Dec 31, 2024
Primary Outcome
Pain score at rest 0-72 hours after surgery
Summary
The goal of this clinical trial] is to further explore the effectiveness and safety of
 oxelidine in the treatment of moderate to severe acute pain after orthopedic surgery. The
 main question it aims to answer is: Pain management after orthopaedic surgery provides more
 effective and safe drug options, provides new options for clinical treatment, and provides a
 scientific basis for clinical practice.
 
 Participants will be asked to pain score in the different time, treatments they'll be given
 and use optimal drug. Researchers will compare analgesic effect of oxelidine of different
 dose.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06320041
Non-Device Trial